Compare Cytokinetics Inc (CYTK) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs F5 Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: F5 Inc is far larger — about 2.2× Cytokinetics Inc's market cap, and F5 Inc is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | FFIV | |
|---|---|---|
Market Cap | $10.63B | $23.44B |
Sector | Technology | Technology |
52-Week High | $87.26 | $431.26 |
52-Week Low | $34.31 | $223.99 |
Enterprise Value | $10.74B | $22.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
